Paranoid Schizophrenia is Characterized by Increased CB1 Receptor Binding in the Dorsolateral Prefrontal Cortex
出版年份 2011 全文链接
标题
Paranoid Schizophrenia is Characterized by Increased CB1 Receptor Binding in the Dorsolateral Prefrontal Cortex
作者
关键词
-
出版物
NEUROPSYCHOPHARMACOLOGY
Volume 36, Issue 8, Pages 1620-1630
出版商
Springer Nature
发表日期
2011-04-07
DOI
10.1038/npp.2011.43
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Selection of Reference Gene Expression in a Schizophrenia Brain Cohort
- (2010) Cynthia Shannon Weickert et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Increased Interstitial White Matter Neuron Density in the Dorsolateral Prefrontal Cortex of People with Schizophrenia
- (2010) Yang Yang et al. BIOLOGICAL PSYCHIATRY
- Effects of the Cannabinoid-1 Receptor Antagonist Rimonabant on Psychiatric Symptoms in Overweight People With Schizophrenia
- (2010) Deanna L. Kelly et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR
- (2010) Dean F. Wong et al. NEUROIMAGE
- Human brain weight is correlated with expression of the ‘housekeeping genes’ beta-2-microglobulin (β2M) and TATA-binding protein (TBP)
- (2010) P. J. Harrison et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder
- (2010) Stephen M Eggan et al. NEUROPSYCHOPHARMACOLOGY
- Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia
- (2010) J. Wong et al. NEUROSCIENCE
- IN VIVO PET IMAGING OF CEREBRAL TYPE 1 CANNABINOID RECEPTOR AVAILABILITY IN PATIENTS WITH SCHIZOPHRENIA
- (2010) Jenny Ceccarini et al. SCHIZOPHRENIA RESEARCH
- Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists
- (2010) Patrik Roser et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Cannabis and psychosis/schizophrenia: human studies
- (2009) Deepak Cyril D’Souza et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- S39-02 Antipsychotic effects of cannabidiol
- (2009) F.M. Leweke et al. EUROPEAN PSYCHIATRY
- Species differences in cannabinoid receptor 2 (CNR2gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands
- (2009) Q.-R. Liu et al. GENES BRAIN AND BEHAVIOR
- HU210-Induced Downregulation in Cannabinoid CB1 Receptor Binding Strongly Correlates with Body Weight Loss in the Adult Rat
- (2009) Victoria S. Dalton et al. NEUROCHEMICAL RESEARCH
- Risperidone Treatment Increases CB1 Receptor Binding in Rat Brain
- (2009) Anna Secher et al. NEUROENDOCRINOLOGY
- Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment
- (2009) Leyre Urigüen et al. PSYCHOPHARMACOLOGY
- Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia
- (2008) Iván Chavarría-Siles et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
- (2008) Stephen M. Eggan et al. ARCHIVES OF GENERAL PSYCHIATRY
- Reliability of Post-Mortem Psychiatric Diagnosis for Neuroscience Research
- (2008) Nina Sundqvist et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain
- (2008) Katrina Weston-Green et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus
- (2008) A. Ludanyi et al. JOURNAL OF NEUROSCIENCE
- Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats
- (2008) Jenny L. Wiley et al. NEUROPHARMACOLOGY
- Psychosis Following Anti-Obesity Treatment with Rimonabant
- (2008) Tarik Ugur et al. Obesity Facts
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now